CD72 is a co-receptor of B cells and regulates B cell activation. Although aberrant expression of CD72 has been reported in primary immune thrombocytopenia (ITP), it is uncertain whether this aberrant expression is restricted to specific B cell subsets. Furthermore, the mechanisms that regulate CD72 expression are unknown. In this study, we found higher frequency of CD19 B cells, CD19 CD27 memory B cells and lower frequency of CD19 CD27 naive B cells in active ITP patients compared with controls and patients in remission. CD72 expression on CD19 CD27 cells was upregulated in active ITP patients and correlated with platelet count and anti-platelet autoantibodies. In vitro, CD40L could specifically induce CD72 upregulation on CD19 CD27 B cells. In combination with CD40L, interleukin (IL) 10 and BAFF (also termed TNFSF13B) further enhanced CD72 expression on CD19 CD27 B cells, whereas IL21 reduced CD72 upregulation. CD72mRNA expression after CD40L stimulation was increased in ITP patients and controls. Significant increase of CD40L on CD4 T cells was correlated with CD72 expression on CD19 CD27 B cells in ITP patients. In conclusion, upregulation of CD72 expression on CD27 memory B cells might take part in the pathogenesis of ITP. Elevated CD40L on CD4 cells combined with cytokines might contribute to the upregulation of CD72 expression on CD27 memory B cells.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/bjh.14671 | DOI Listing |
BMC Rheumatol
November 2024
PABIOM Laboratory, Faculty of Medicine and Biomedical Sciences, Autonomous University of Chihuahua, Circuito Universitario Campus II, Chihuahua, CP, 31125, Mexico.
Background: Intermittent fasting (IF) has shown benefits in various pathological conditions. Although its anti-inflammatory potential has been recognized, its effects on the mechanism underlying rheumatoid arthritis (RA) remain insufficiently characterized. This study aimed to investigate the effects of IF in a murine model of RA.
View Article and Find Full Text PDFExp Neurol
December 2024
Department of Neurosurgery, Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou 215006, China; Institute of Stroke Research, Soochow University, Suzhou 215006, China. Electronic address:
Ischemic stroke remains a leading cause of global mortality and disability, with neuroinflammation playing a critical role in determining patient outcomes. Microglia, the brain's resident immune cells, can both exacerbate neuroinflammation and neuronal damage by releasing neurotoxic mediators and engaging in excessive phagocytosis, while also aiding recovery through the production of anti-inflammatory cytokines and debris clearance. However, the molecular mechanisms governing microglial activation and polarization after ischemic stroke are not well elucidated.
View Article and Find Full Text PDFFront Microbiol
August 2024
Hunan Provincial Key Laboratory of Plant Diseases and Pests, College of Plant Protection, Hunan Agricultural University, Changsha, Hunan, China.
Introduction: Reactive oxygen species (ROS) generation is a common disease defense mechanism in plants. However, it is unclear whether host activates defense response against causing citrus melanose disease by producing ROS, and the underlying molecular mechanisms are unknown.
Methods: DAB staining and RNA-Seq technology were used to compare the active oxygen burst and differential gene expression, respectively, in uninfected and infected leaves at different time points during infection .
Int Immunopharmacol
December 2024
Key laboratory of Cellular Physiology, Shanxi Medical University, Ministry of Education, Taiyuan 030000, Shanxi, China; Department of Pharmacology, Shanxi Medical University, Taiyuan 030000, Shanxi, China; Higher Education Key Laboratory of Tumor Immunology & Targeted Drug Development in Shanxi Province, Shanxi Medical University, Taiyuan 030000, Shanxi, China. Electronic address:
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma and has a poor prognosis. Despite the impressive advancements in treating ccRCC using immune checkpoint (IC) blockade, such as PD-1/PD-L1 inhibitors, a considerable number of ccRCC patients experience adaptive resistance. Therefore, exploring new targetable ICs will provide additional treatment options for ccRCC patients.
View Article and Find Full Text PDFSci Rep
September 2024
Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, VA, 23507, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!